In melanoma, Ma et al. showed that patients bearing melanomas with a high autophagic index were less likely to respond to treatment (temozolomide and sorafenib), and autophagy inhibition using either hydroxychloroquine or inducible shRNA against Atg5 led to a significant augmentation of temozolomide-induced cell death [49]. Here, ATG5 is linked to melanoma.